Urgent Stryker Rejuvenate Safety Notice – Stryker has Recalled its Rejuvenate and ABG II Hip Replacement Implants
In the three years since Stryker first introduced the Rejuvenate and ABG II modular hip implant systems, thousands of patients have had these devices implanted. The devices were distributed by Stryker throughout the United States.
The promises made about the Rejuvenate seem to have all been false. Since the device does not contain a metal on metal ball and cup, the Rejuvenate was supposed to avoid all of the problems associated with metal on metal bearing surface metal toxicity failures. In addition, since the device was “modular” it supposedly provided the surgeon with more options to get the perfect “fit” thereby providing the prospect of longer lasting replacements in young, active patients.
In the short time since Rejuvenate’s launch in 2009, adverse event reports have been piling up in the FDA’s adverse event database. Although no Stryker Rejuvenate lawsuits have been filed to our knowledge, they are certainly to follow Stryker’s abrupt recall of the device.
Now that the device has been recalled, what are patients to do? Many have been experiencing unexplained pain for some time. For those patients, the decision to have the device removed is simple. Especially after the doctor explains the danger of tissue death, muscle loss and systemic effects of heavy metal poisoning. At least for them, they now know that metal toxicity is the most likely cause of their pain. They are not crazy.
For those patients who have no symptoms, the decision is much more complicated. Doctors and their patients will have to weigh the risks of undergoing a revision surgery against the potential that the device will ultimately fail and cause metal related toxicity issues.
Since we have spoken with and represent many victims of the defective, recalled Rejuvenate, we may be able to provide new clients with the benefit of other patient’s experiences to help guide them.